Works matching IS 09697128 AND DT 2008 AND VI 15 AND IP 1

Results: 10

Regulated expression of the interferon-β gene in mice.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 1, doi. 10.1038/sj.gt.3302998

By:

Harkins, R. N.;
Szymanski, P.;
Petry, H.;
Brooks, A.;
Qian, H. S.;
Schaefer, C.;
Kretschmer, P. J.;
Orme, A.;
Wang, P.;
Rubanyi, G. M.;
Hermiston, T. W.

Publication type:

Article

The cHS4 chromatin insulator reduces gammaretroviral vector silencing by epigenetic modifications of integrated provirus.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 49, doi. 10.1038/sj.gt.3303009

By:

Li, C. L.;
Emery, D. W.

Publication type:

Article

Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 40, doi. 10.1038/sj.gt.3303049

By:

Zhang, H.;
Zhu, S.-J.;
Wang, W.;
Wei, Y.-J.;
Hu, S.-S.

Publication type:

Article

A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.

Published in:

2008

By:

Riezebos-Brilman, A.;
Walczak, M.;
Regts, J.;
Rots, M. G.;
Kamps, G.;
Dontje, B.;
Haisma, H. Y.;
Wilschut, J.;
Daemen, T.

Publication type:

Correction Notice

Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 12, doi. 10.1038/sj.gt.3303035

By:

Raake, P. W.;
Hinkel, R.;
Müller, S.;
Delker, S.;
Kreuzpointner, R.;
Kupatt, C.;
Katus, H. A.;
Kleinschmidt, J. A.;
Boekstegers, P.;
Müller, O. J.

Publication type:

Article

Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer.

Published in:

2008

By:

Hoffmann, D.;
Bangen, J. M.;
Bayer, W.;
Wildner, O.

Publication type:

Correction Notice

Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 54, doi. 10.1038/sj.gt.3303037

By:

Petry, H.;
Brooks, A.;
Orme, A.;
Wang, P.;
Liu, P.;
Xie, J.;
Kretschmer, P.;
Qian, H. S.;
Hermiston, T. W.;
Harkins, R. N.

Publication type:

Article

DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of mice.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 61, doi. 10.1038/sj.gt.3303044

By:

Mkrtichyan, M.;
Ghochikyan, A.;
Loukinov, D.;
Davtyan, H.;
Ichim, T. E.;
Cribbs, D. H.;
Lobanenkov, V. V.;
Agadjanyan, M. G.

Publication type:

Article

Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 18, doi. 10.1038/sj.gt.3303046

By:

Russ, V.;
Elfberg, H.;
Thoma, C.;
Kloeckner, J.;
Ogris, M.;
Wagner, E.

Publication type:

Article

Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice.

Published in:

Gene Therapy, 2008, v. 15, n. 1, p. 30, doi. 10.1038/sj.gt.3303048

By:

Shen, F.;
Fan, Y.;
Su, H.;
Zhu, Y.;
Chen, Y.;
Liu, W.;
Young, W. L.;
Yang, G.-Y.

Publication type:

Article